What is the difference between Pinealon and Epithalon?

Both are pineal gland-derived peptide bioregulators from the Khavinson group at the Saint Petersburg Institute of Bioregulation and Gerontology. Epithalon (Ala-Glu-Asp-Gly / AEDG tetrapeptide) targets systemic aging through telomerase activation and broad pineal gland regulation — anti-aging effects across multiple tissues. Pinealon (Glu-Asp-Arg / EDR tripeptide) is specifically directed at brain and nervous system tissue — neuroprotection, cognitive aging, antioxidant brain defense, and circadian support. They're complementary: one systemic, one CNS-targeted. The standard Khavinson stack uses both together.

What human evidence exists for Pinealon?

Human evidence for Pinealon is limited — primarily Russian clinical studies from the Khavinson research group. The key human study (Khavinson et al., Advances in Gerontology 2012) found that Pinealon treatment improved cognitive performance scores and quality of life metrics in elderly patients with cognitive impairment vs. controls. This is published peer-reviewed research, but from a single research group, in a Russian-language journal, with limited methodological detail available in English. No Western-standard RCTs have been conducted. The preclinical evidence (neuroprotection in hypoxia models, antioxidant effects in brain tissue) is better replicated.

Why do biohackers use Pinealon alongside Epithalon?

The pairing is mechanistically rational: Epithalon handles systemic aging (telomere maintenance, pineal gland regulation broadly), while Pinealon handles CNS-specific aging (neuroprotection, cognitive aging, brain antioxidant defense). The two compounds have the same cycle structure (10-20 days), same dosing frequency (daily SC), and same developer. Running them together is simpler than separate cycles and covers complementary aging pathways. The extended longevity brain stack — Epithalon + Pinealon + Semax + NAD+ — is a popular combination addressing systemic aging, CNS protection, BDNF-driven cognitive enhancement, and mitochondrial fuel.

How reliable is the Khavinson group research?

The Khavinson group's research is real published science in peer-reviewed journals with decades of consistent findings across the bioregulator peptide series. Limitations remain: most human longevity data comes from one research program, many studies are in Russian-language journals, and Western RCT longevity outcomes are absent. Epithalon telomerase/telomere effects were independently replicated in human cell lines in 2025 (Al-Dulaimi et al.); that does not extend to Pinealon clinical claims. Calibrate confidence to evidence type — mechanistic and observational, not proven by Western clinical trial standards.

COMPOUND LIBRARY·BIOREGULATOR SERIES·PINEALON

◈ Part of the Bioregulator Series →

Also in the Bioregulator Series

EpithalonAEDG CortagenAEDP Thymalin View all →

COMPOUND PROFILE · PEPPERLEDGER

Pinealon (EDR)

Type

Synthetic tripeptide bioregulator — Glu-Asp-Arg (EDR) — Khavinson group, Saint Petersburg Institute of Bioregulation and Gerontology

Class

Neuroprotective peptide · Circadian regulator · Antioxidant · Brain-specific anti-aging bioregulator — CNS companion to Epithalon

Administration

Subcutaneous injection · Intranasal · Oral (bioavailability not established)

Half-life

Short — tripeptide; effects via gene regulatory interactions in brain tissue

Most studied use

Neuroprotection · Cognitive aging · Circadian rhythm support · Antioxidant brain protection · Longevity stack with Epithalon

Regulatory status

Not FDA-approved · Research chemical · Same status as Epithalon · Used in Russian clinical practice

Human evidence

Limited — Russian clinical studies primarily from Khavinson group; no Western RCTs

Preclinical evidence

Moderate — neuroprotective, antioxidant, and circadian effects in multiple animal models

EDUCATIONAL TOOL — NOT MEDICAL ADVICE

What is Pinealon?

Pinealon is the brain-specific companion to Epithalon in the Khavinson group's peptide bioregulator series. Where Epithalon (AEDG) targets systemic aging through telomerase activation and pineal gland regulation broadly, Pinealon (EDR) is specifically a brain and nervous system bioregulator — derived from pineal gland tissue but directed at neural tissue protection, cognitive function, and brain antioxidant defense.

The Khavinson group at the Saint Petersburg Institute of Bioregulation and Gerontology has developed a systematic library of short peptide bioregulators derived from different organs — thymus (Vilon, Thymalin), pineal gland (Epithalon, Pinealon), blood vessels (Vesugen), bone marrow (Bonomarlot), and others. Each is proposed to exert tissue-specific regulatory effects on the organ from which it's derived. Pinealon's specificity for brain tissue is the theoretical basis for its cognitive and neuroprotective applications.

For biohackers, Pinealon and Epithalon are typically used together as a longevity stack: Epithalon for systemic telomere maintenance and broad anti-aging effects, Pinealon specifically for brain and nervous system protection. The evidence base has the same single-group limitation as Epithalon — primarily from the Khavinson research program with limited independent replication. The evidence is meaningful within that context; it is not equivalent to Western-standard multicenter RCTs.

How it works

Brain Tissue-Specific Bioregulation

Pinealon (EDR tripeptide) is proposed to interact with regulatory sequences in brain tissue gene promoters — the Khavinson group's broader theory for short peptide bioregulators is that they regulate gene expression in a tissue-specific manner by interacting with chromatin and transcription factors. In brain tissue specifically, Pinealon is proposed to regulate genes involved in neuronal survival, antioxidant defense, and synaptic function. The exact molecular target is less well-characterized than CNTF pathway (P21) or BDNF pathway (Semax).

Antioxidant Protection

Pinealon reduces oxidative stress markers in brain tissue — upregulating SOD (superoxide dismutase) and catalase, reducing lipid peroxidation. The brain is particularly vulnerable to oxidative damage due to its high metabolic rate and oxygen consumption; antioxidant protection of neural tissue is mechanistically important for cognitive aging and longevity.

Neuroprotection Against Hypoxia and Ischemia

In animal models of cerebral hypoxia and ischemia, Pinealon reduces neuronal death, preserves cognitive function post-ischemia, and improves recovery. This neuroprotective mechanism — whether via antioxidant effects, anti-apoptotic signaling, or gene regulation — is consistent across the preclinical literature.

Circadian and Sleep Support

As a pineal gland-derived peptide, Pinealon influences circadian regulation and melatonin production patterns — similar to Epithalon but with stronger CNS specificity. Improved sleep quality and circadian rhythm support are consistent community and clinical reports, and align mechanistically with the pineal gland origin of the compound.

What the research shows

NOTE — PRIMARILY KHAVINSON GROUP · LIMITED INDEPENDENT CLINICAL REPLICATION

STUDYMolecules · 2020

EDR peptide: possible mechanism of gene-expression and protein-synthesis regulation in the pathogenesis of Alzheimer's disease

Khavinson V, Linkova N, Kozhevnikova E, Trofimova S

Khavinson-group review of how the EDR tripeptide (Pinealon) regulates gene expression and protein synthesis to support neuronal survival and reduce apoptosis. It also summarizes the human side: oral Pinealon is reported to correct age-related cerebral dysfunction and improve memory, attention, and cognitive function in older adults. A mechanistic-plus-clinical-summary review from the developing group — secondary Russian-bioregulator literature, not an independent RCT.

View on PubMed →

STUDYRejuvenation Research · 2011

Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes

Khavinson VK et al.

The mechanistic paper. Pinealon (the Glu-Asp-Arg / EDR tripeptide) dose-dependently curbed reactive-oxygen-species accumulation in cerebellar granule neurons, neutrophils, and PC12 cells under oxidative stress and cut necrotic cell death — accompanied by delayed ERK1/2 activation and cell-cycle changes favoring survival. Establishes Pinealon's antioxidant, cytoprotective mechanism in neuronal cells.

View on PubMed →

STUDYPharmaceuticals (Basel) · 2021

Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease

Khavinson V, Ilina A, Kraskovskaya N et al.

In 5xFAD Alzheimer's-model mice treated from 2-4 months of age, both tripeptides prevented dendritic spine loss — EDR (Pinealon) specifically improved spine density and mushroom spine numbers in both sexes, while it was KED (Vesugen) that tended to increase neuroplasticity on hippocampal LTP and that the proposed mechanism credits with reduced endothelial and neuronal apoptosis. Both peptides bind promoter regions of Alzheimer's-related genes including CASP3, APOE and SOD2. Multi-peptide paper — cited here because EDR is a named intervention.

View on PubMed →

WHAT THE RESEARCH SHOWS

✓KNOWN

✓Antioxidant effects in brain tissue — SOD/catalase upregulation, lipid peroxidation reduction
✓Neuroprotection in hypoxia and ischemia animal models
✓Cognitive improvement in elderly patients — Russian clinical study
✓Circadian and sleep support consistent with pineal gland origin

?UNCERTAIN

?Exact molecular target and receptor mechanism
?Independent clinical replication outside the Khavinson group (Epithalon telomere work has 2025 in vitro replication; Pinealon does not)
?Western-standard RCT data
?Optimal dosing and cycle structure for cognitive aging

What the community reports

—Improved sleep quality and depth — most consistently reported early effect; consistent with circadian/pineal mechanism; often noticed within the first week of a course

—Cognitive clarity — described as background improvement rather than acute sharpening; consistent with neuroprotective rather than neurostimulant mechanism

—Stacked invariably with Epithalon — the Epithalon + Pinealon combination is the standard Khavinson bioregulator stack; almost never used alone

—The longevity brain stack: Epithalon + Pinealon + Semax + NAD+ — systemic aging, CNS protection, acute cognitive enhancement, mitochondrial fuel

—Same epistemic limitation awareness as Epithalon — users who run these compounds tend to have read the research and calibrated their confidence to the evidence quality

Common misconceptions

"Pinealon and Epithalon are interchangeable."

REALITY

Both are pineal gland-derived Khavinson peptides but different sequences with different proposed specificity. Epithalon (AEDG tetrapeptide) targets telomerase activation and systemic aging broadly. Pinealon (EDR tripeptide) is the brain/nervous system-specific bioregulator. They're complementary, not the same compound.

"The Russian clinical evidence equals Western RCT evidence."

REALITY

The Khavinson group's research is real published science, but lacks the methodological rigor and sample sizes of Western multicenter RCTs. Related Epithalon telomere work has independent in vitro replication (2025); Pinealon clinical data does not. Calibrate confidence accordingly.

LONGEVITY BRAIN STACK — LAYERED MECHANISMS

Pinealon: CNS-specific neuroprotection + antioxidant + circadian. Epithalon: systemic anti-aging, telomerase activation, broad pineal regulation. Semax: acute BDNF upregulation and cognitive sharpening. Cerebrolysin: broadest neuroprotection with the most clinical evidence.

RECONSTITUTION CALCULATOR

Peptide in vial (mg)BAC water (mL)Desired dose (mcg)

EDUCATIONAL TOOL — NOT MEDICAL ADVICE · VERIFY WITH YOUR CLINICIAN

AI RESEARCHER PREVIEW

I'm running Epithalon. Should I add Pinealon and how do they differ?

Adding Pinealon to an Epithalon course is a mechanistically rational decision — let me explain why, and what to expect from each. What Epithalon is doing: telomere protection via telomerase activation, broad pineal gland regulation, systemic anti-aging effects. The evidence is concentrated in lifespan extension and circadian restoration. What Pinealon adds that Epithalon doesn't: brain-specific neuroprotection. Epithalon covers the systemic aging and pineal aspects broadly. Pinealon is proposed to specifically target brain and nervous system tissue — upregulating antioxidant enzymes (SOD, catalase), protecting neurons from hypoxic damage, and supporting cognitive function in aging. They're the same origin (pineal gland, Khavinson group) but different sequences with different tissue targets. The combination gives you: systemic anti-aging (Epithalon) + CNS-specific neuroprotection (Pinealon). Same cycle structure — both run 10-20 days daily SC, 2-4 times per year. Run them simultaneously rather than in separate cycles for simplicity. Timing: evening — aligns with circadian/pineal biology and overnight neural repair. What to track when adding Pinealon: sleep quality is the most reliable early signal. Most users notice sleep depth improvement within the first week. Track it nightly on a simple scale. Cognitive function — consistent daily metric if you want to capture that. General wellbeing and energy weekly. The epistemic calibration: Pinealon's evidence is from the same Khavinson group as Epithalon — compelling enough to explore, not proven by Western RCT standards. Same confidence level as Epithalon. What cycle of Epithalon are you on — first, or have you run it before?

CONTINUE IN THE APP

Open PepperLedger to track your Pinealon protocol →

Free to join. No credit card. Ask the Researcher about your longevity peptide stack once you're in.

Free to join · No credit card · 23-day Pro trial included